Acute stress disorder and C-reactive protein in patients with acute myocardial infarction

Abstract

Get full access to this article

View all access options for this article.

References

Westman

Lipinski

Luger

et al.

Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2016; 67(17): 2050–2060.

Reindl

Reinstadler

Feistritzer

et al.

Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care 2017; 6(7): 640–649.

Caixeta

Stone

Mehran

et al.

Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: An analysis from the ACUITY trial. J Thromb Thrombolysis 2011; 31(2): 154–164.

Meder

Rühle

Weis

et al.

A genomewide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J 2014; 35: 1069–1077.

Ridker

MacFadyen

Everett

et al.

CANTOS Trial Group. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: A secondary analysis from the CANTOS randomised controlled trial. Lancet 2018; 391: 319–328.

Ridker

Everett

Thuren

et al.

CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377(12): 1119–1131.

Slobodnick

Shah

Krasnokutsky

et al.

Update on colchicine, 2017. Rheumatology (Oxford) 2018; 57(Suppl. 1): i4–i11.

Vaidya

Arnott

Martínez

et al.

Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: A CT coronary angiography study. JACC Cardiovasc Imaging 2018; 11(2 Pt 2): 305–316.

Nidorf

Eikelboom

Budgeon

et al.

Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol 2013; 61(4): 404–410.

10.

Ørn

Ueland

Manhenke

et al.

Increased interleukin-1b levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention. J Intern Med 2012; 272: 267–276.

11.

Meister

Weber

Princip

et al.

Perception of a hectic hospital environment at admission relates to acute stress disorder symptoms in myocardial infarction patients. Gen Hosp Psychiatry 2016; 39: 8–14.

12.

von Känel

Hari

Schmid

et al.

Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. J Cardiol 2011; 58(1): 61–68.

13.

Ginzburg

Solomon

Bleich

. Repressive coping style, acute stress disorder, and posttraumatic stress disorder after myocardial infarction. Psychosom Med 2002; 64: 748–757.

14.

Meister

Weber

Princip

et al.

Resilience as a correlate of acute stress disorder symptoms in patients with acute myocardial infarction. Open Heart 2015; 2(1): e000261–e000261.

15.

Ginzburg

Kutz

Koifman

et al.

Acute stress disorder symptoms predict all-cause mortality among myocardial infarction patients: A 15-year longitudinal study. Ann Behav Med 2016; 50: 177–186.

16.

Zhou

Dreyer

et al.

Sex differences in inflammatory markers and health status among young adults with acute myocardial infarction: Results from the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients) study. Circ Cardiovasc Qual Outcomes 2017; 10(2): e003470–e003470.

17.

Edmondson

Richardson

Falzon

et al.

Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: A meta-analytic review. PLoS One 2012; 7(6): e38915–e38915.

18.

Ginzburg

Ein-Dor

. Posttraumatic stress syndromes and health-related quality of life following myocardial infarction: 8-year follow-up. Gen Hosp Psychiatry 2011; 33(6): 565–571.

19.

Baker

Nievergelt

O’Connor

. Biomarkers of PTSD: Neuropeptides and immune signaling. Neuropharmacology 2012; 62(2): 663–673.

20.

Spitzer

Barnow

Völzke

et al.

Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: Evidence from the general population. J Psychiatr Res 2010; 44(1): 15–21.

21.

Milwidsky

Ziv-Baran

Letourneau-Shesaf

et al.

CRP velocity and short-term mortality in ST segment elevation myocardial infarction. Biomarkers 2017; 22(3–4): 383–386.

22.

Bielas

Meister-Langraf

Schmid

et al.

Acute stress disorder and C-reactive protein in patients with acute myocardial infarction. Eur J Prev Cardiol 2018; 25(3): 298–305.

23.

Helfricht

Landolt

Moergeli

et al.

Psychometric evaluation and validation of the German version of the Acute Stress Disorder Scale across two distinct trauma populations. J Trauma Stress 2009; 22: 476–480.

24.

Mitchell

Powell

Blumenthal

et al.

A short social support measure for patients recovering from myocardial infarction: The ENRICHD Social Support Inventory. J Cardiopulm Rehabil 2003; 23: 398–403.

25.

Ridker

Cook

. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004; 109: 1955–1959.

26.

Ginzburg

Kutz

Koifman

et al.

Acute stress disorder symptoms predict all-cause mortality among myocardial infarction patients: A 15-year longitudinal study. Ann Behav Med 2016; 50(2): 177–186.

27.

Heffner

Waring

Roberts

et al.

Social isolation, C-reactive protein, and coronary heart disease mortality among community-dwelling adults. Soc Sci Med 2011; 72: 1482–1488.

28.

Cohen

Wills

. Stress, social support, and the buffering hypothesis. Psychol Bull 1985; 98: 310–357.

29.

Pedersen

von Känel

Tully

et al.

Psychosocial perspectives in cardiovascular disease. Eur J Prev Cardiol 2017; 24(3 Suppl.): 108–115.

30.

Barth

Schneider

von Känel

. Lack of social support in the etiology and the prognosis of coronary heart disease: A systematic review and meta-analysis. Psychosom Med 2010; 72: 229–238.

31.

Fox KA, Dabbous OH, Goldberg RJ et al. Prediction of risk of death and myocardial infarction in the 6 months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333: 1091–4.

32.

Stein

Koenen

Friedman

et al.

Dissociation in posttraumatic stress disorder: Evidence from the world mental health surveys. Biol Psychiatry 2013; 73: 302–312.

33.

Roberge

M-A

Dupuis

Marchand

. Posttraumatic stress disorder following myocardial infarction: prevalence and risk factors. Can J Cardiol 2010; 26: e170–e175.

34.

Pogosova

Kotseva

De Bacquer

et al.

Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. Eur J Prev Cardiol 2017; 24: 1371–1380.

35.

Meister

Princip

Schmid

et al.

Myocardial Infarction – Stress PRevention INTervention (MI-SPRINT) to reduce the incidence of posttraumatic stress after acute myocardial infarction through trauma-focused psychological counseling: Study protocol for a randomized controlled trial. Trials 2013; 14: 329–329.